Tag: Antiviral treatment

In a real-world study, adults who took Paxlovid within five days of a COVID-19 diagnosis had a 51% lower hospitalization rate [1.2.2]. However, this antiviral medication is not suitable for everyone, and it's crucial to understand **who should avoid taking Paxlovid** to prevent serious health risks.

Paxlovid, an oral antiviral, reduced the risk of COVID-19 hospitalization or death by 86% in one clinical trial. However, due to significant drug interactions or other contraindications, some patients require an alternative. So, what is a substitute for Paxlovid?

Chandipura virus (CHPV) is an emerging pathogen with a high case-fatality ratio, ranging from 56-75%, particularly in children [1.2.1, 1.5.3]. Given its severity, the crucial question is: what drugs are used to treat Chandipura virus?